Whither triclosan?

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 5, 2004, Pages 693-695

  Russell, A D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antibiotic resistance; Mechanisms of action; Mechanisms of resistance

Indexed keywords

OXIDOREDUCTASE; TRICLOSAN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONCENTRATION RESPONSE; DRUG USE; ENVIRONMENT; ENZYME INHIBITION; ENZYME SYNTHESIS; FUNGUS SPORE; GENE MUTATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS, LOCAL; DRUG RESISTANCE, BACTERIAL; TRICLOSAN;

EID: 2442694102     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh171     Document Type: Article

References (49)

1. Parfitt, K. (1999). In Martindale, The Complete Drug Reference, p. 1127. Pharmaceutical Press, London, UK.
2. Jones, R. D., Jampani, H. B., Neman, J. L. et al. (2000). Triclosan: a review of effectiveness and safety in health care settings. American Journal of Infection Control 28, 184-96.
3. Schweizer, H. P. (2001). Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiology Letters 202, 1-7.
4. McLeod, R., Muench, S. P., Rafferty, J. B. et al. (2001). Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicompexan Fabl. International Journal of Parasitology 31, 109-13.
5. Ciba-Geigy. (1988). Document: Irgasan DP 300. Ciba, Wyhlen, Germany.
6. Al-Doori, Z., Morrison, D., Edwards, G. et al. (2003). Susceptibility of MRSA to triclosan. Journal of Antimicrobial Chemotherapy 51, 185-6.
7. Suller, M. T. E. & Russell, A. D. (1999). Antibiotic and biocide resistance in methicillin-resistant Staphylococcus, aureus and vancomycin-resistant enterococcus. Journal of Hospital Infection 43, 281-91.
8. Suller, M. T. E. & Russell, A. D. (2000). Triclosan and antibiotic resistance in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 46, 11-8.
9. McMurry, L. M., Oethinger, M. & Levy, S. B. (1998). Triclosan targets lipid synthesis. Nature 394, 531-2.
10. McMurry, L. M., Oethimger, M. & Levy, S. B. (1998). Over-expression of marA, soxS or acrAB produces resistance to triclosan in Escherichia coli. FEMS Microbiology Letters 186, 305-9.
11. Russell, A. D. (2003). Similarities and differences in the responses of microorganisms to biocides. Journal of Antimicrobial Chemotherapy 52, 750-63.
12. Levy, C. W., Roujeinikova, A., Sedelnikova, S. et al. (1999). Molecular basis of triclosan activity. Nature 398, 383-4.
13. Heath, R. J. & Rock, C. O. (2000). A triclosan-resistant bacterial enzyme. Nature 406, 145-6.
14. McMurry, L. M., McDermott, P. F. & Levy, S. B. (1999). Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrobial Agents and Chemotherapy 43, 711-3.
15. Russell, A. D. (2002). Mechanisms of antimicrobial action of anti-septics and disinfectants: an increasingly important area of investigation. Journal of Antimicrobial Chemotherapy 49, 597-9.
16. Russell, A. D. (2003). Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infectious Diseases 3, 794-803.
17. McDonnell, G. & Pretzer, D. (1998). Action and targets of triclosan. ASM News 84, 670-1.
18. Villalain, J., Mateo, C. R., Aranda, F. J. et al. (2001). Membranotropic effects of the antibacterial agent triclosan. Archives of Biochemistry and Biophysics 390, 128-36.
19. Denyer, S. P. & Maillard, J.-Y. (2002). Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria. Journal of Applied Microbiology 92, 35S-45S.
20. Heath, R. J., White, S. W. & Rock, C. O. (2001). Lipid biosynthesis as a target for antibacterial agents. Progress in Lipid Research 40, 467-97.
21. Lear, J. C., Maillard, J.-Y., Dettmar, P. W. et al. (2002). Chloroxylenol- and triclosan-tolerant bacteria from industrial sources. Journal of Industrial Microbiology and Biotechnology 29, 238-42.
22. Chuanchen, R., Beinlich, K., Hoang, T. T. et al. (2001). Cross-resistance between triclosan and antibiotics is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxb mutants overexpressing MexCD-OprJ. Antimicrobial Agents and Chemotherapy 45, 428-32.
23. Beinlich, K. I., Chuanchen, R. & Schweizer, H. P. (2001). Contribution of multidrug efflux pumps to multiple antibiotic resistance in veterinary isolates of Pseudomonas aeruginosa. FEMS Microbiology Letters 198, 129-34.
24. Chuanchen, R., Karkhoff-Schweizer, R. R. & Schweizer, H. P. (2003). High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. American Journal of Infection Control 31, 124-7.
25. Bamber, A. I. & Neal, T. J. (1999). An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Journal of Hospital Infection 41, 107-9.
26. Fan, F., Yan, K., Wallis, G. S. et al. (2002). Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 46, 3343-7.
27. Parikh, S. I., Xiao, G. & Tonge, P. J. (2000). Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid. Biochemistry 39, 7645-50.
28. Slayden, R. A., Lee, R. E. & Barry, C. E., 3rd (2000). Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium. Molecular Microbiology 38, 514-25.
29. Russell, A. D. (2000). Do biocides select for antibiotic resistance? Journal of Pharmacy and Pharmacology 52, 227-33.
30. Poole, K. (2002). Mechanisms of bacterial biocide and antibiotic resistance. Journal of Applied Microbiology 92, 55S-64S.
31. Levy, S. B. (2001). Antibacterial household products: cause for concern. Emerging Infectious Diseases 7, Suppl. 3, 512-5.
32. White, D. G. & McDermott, P. F. (2001). Biocides, drug resistance and microbial evolution. Current Opinions in Microbiology 4, 313-7.
33. Levy, S. B. (2002). Factors impacting on the problem of antibiotic resistance. Journal of Antimicrobial Chemotherapy 49, 25-30.
34. Gilbert, P. & McBain, A. J. (2001). Biocide usage in the domestic setting and concern about antibacterial and antibiotic resistance. Journal of Infection 43, 85-91.
35. McBain, A. J., Rickard, A. H. & Gilbert, P. (2002). Possible implications of biocide accumulation in the environment on the prevalence of bacterial antibiotic resistance. Journal of Industrial Microbiology and Biotechnology 29, 326-30.
36. Lambert, R. J. W., Graf, J. F. & Sedlak, R. I. (2002). Antimicrobial resistance and cross-resistance in several bacterial species between 1989 and 2000. In Program and Abstracts of the Forty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, USA, 2002. Abstract C2-1127, p. 103. American Society for Microbiology, Washington, DC, USA.
37. Marshall, B. M., Robleto, E., Dumont, T. et al. (2003). The frequency of bacteria and antibiotic resistance in homes that use and do not use surface antibacterial agents. In 103rd General Meeting of the American Society for Microbiology, Washington, DC, USA, 2003. Abstract A-147. American Society for Microbiology, Washington, DC, USA.
38. Cole, E. C., Addison, R. M., Rubino, J. R. et al. (2003). Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers. Journal of Applied Microbiology 95, 664-76.
39. Expert Panel. (2000). Laboratory and clinical evidence documenting the microbiologic safety of Colgate Total®. Biological Therapies in Dentistry 16, 17-20.
40. Sullivan, A., Wretlind, B. & Nord, C. E. (2003). Will triclosan in toothpaste select for resistant oral streptococci? Clinical Microbiology & Infection 9, 306-9.
41. McBain, A. J., Ledder, R. G., Sreenivasan, P. et al. (2004). Selection for high-level resistance by chronic triclosan exposure is not universal. Journal of Antimicrobial Chemotherapy 53, DOI: 10.1093/jac/dkh168.
42. Health Council of The Netherlands. (2001). Disinfectants in Consumer Products. Publication No. 2001/05E. Health Council of The Netherlands, The Hague, The Netherlands.
43. Cozad, A. & Jones, R. D. (2003). Disinfection and the prevention of infectious disease. American Journal of Infection Control 31, 243-54.
44. Tan, L., Nielsen, N. H., Young, D. C. et al. (2002). Use of antimicrobial agents in consumer products. Archives of Dermatology 138, 1082-6.
45. Dixon, B. (2004). Biocides in the kitchen. ASM News 70, 4-5.
46. Adolfsson-Erici, M., Pettersson, M., Parkkonen, J. et al. (2002). Triclosan, a commmonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 46, 1485-9.
47. Stickler, D. J., Jones, G. L. & Russell, A. D. (2003). Control of encrustation and blockage of Foley catheters. Lancet 361, 1435-7.
48. McDevitt, D., Payne, D. J., Holmes, D. J. et al. (2002). Novel targets for the future development of antibacterial agents. Journal of Applied Microbiology 92, 28S-34S.
49. Russell, A. D. (2004). Bacterial adaptation and resistance to anti-septics, disinfectants and preservatives is not a new phenomenon. Journal of Hospital Infection, in press.